Sign for Notice Everyday    Sign Up| Sign In| Link| English|

Our Sponsors

    Receive Latest News

    Feedburner
    Share Us


    Bladder and Prostate Cancer a Pathophysiological Review

    View: 417

    Website http://www.onlinecompliancepanel.com?expDate=Ourglocal | Want to Edit it Edit Freely

    Category 508 compliance; act compliance; fda compliance; ada compliance; advisor compliance; argent software pci compliance; certificate of compliance; code compliance; compliance; compliance audit; compliance checklist; compliance issues; compliance jobs; compliance management; compliance manager; compliance manual; compliance monitoring; compliance monitoring ppt; compliance officer; compliance plan; compliance plans; compliance program; compliance software; compliance solutions; compliance testing; compliance training; compliance with; contract compliance; corporate compliance; email compliance; environmental compliance; export compliance; health care compliance; healthcare compliance; hipaa compliance; hippa compliance; investment advisor compliance; medical compliance; medication compliance; non compliance; osha compliance; osha compliance training; pci compliance; policy compliance; regulatory compliance; rohs compliance; safety compliance; sarbanes oxley compliance; security compliance; sox compliance; tax comp

    Deadline: May 14, 2014 | Date: May 14, 2014

    Venue/Country: 38868 Salmon Ter, Fremont, U.S.A

    Updated: 2014-04-17 18:45:55 (GMT+9)

    Call For Papers - CFP

    Instructor: James Matheny

    Description:

    A Bladder or Prostate Cancer diagnosis is life changing for a patient. As a research professional assigned to oncology trials in any solid organ it is advantageous to have and intermediate understanding of the pathophysiology of the disease process.

    There is a knack to understanding oncology clinical trials, and the skillsets simply do not appear overnight. Many CRAs and coordinators spend years working in cancer therapeutics before feeling moderately comfortable. Most institutions and pharmaceutical clients offer minimal therapeutic training. This training is designed to give clinical and regulatory professionals a working knowledge of bladder and prostate cancers.

    Why Should you Attend:

    To learn about the pathology, physiology, and treatment of both bladder and prostate cancers.

    Objectives of the Presentation:

    Bladder and Prostate - Etiology

    Epidemiology

    Pathology

    Clinical Features and Treatments

    Who can Benefit:

    Research Coordinators

    Regulatory Coordinators

    Data Coordinators

    Clinical Research Associates

    Clinical Research Project Manager

    Contract Research Organizations

    Safety Nurses

    http://www.onlinecompliancepanel.com/ecommerce/webinar/~product_id=500299?expDate=Ourglocal


    Keywords: Accepted papers list. Acceptance Rate. EI Compendex. Engineering Index. ISTP index. ISI index. Impact Factor.
    Disclaimer: ourGlocal is an open academical resource system, which anyone can edit or update. Usually, journal information updated by us, journal managers or others. So the information is old or wrong now. Specially, impact factor is changing every year. Even it was correct when updated, it may have been changed now. So please go to Thomson Reuters to confirm latest value about Journal impact factor.